Repeated N-acetylcysteine Administration Alters Plasticity-dependent Effects of Cocaine
Overview
Authors
Affiliations
Cocaine produces a persistent reduction in cystine-glutamate exchange via system x(c)- in the nucleus accumbens that may contribute to pathological glutamate signaling linked to addiction. System x(c)- influences glutamate neurotransmission by maintaining basal, extracellular glutamate in the nucleus accumbens, which, in turn, shapes synaptic activity by stimulating group II metabotropic glutamate autoreceptors. In the present study, we tested the hypothesis that a long-term reduction in system x(c)- activity is part of the plasticity produced by repeated cocaine that results in the establishment of compulsive drug seeking. To test this, the cysteine prodrug N-acetylcysteine was administered before daily cocaine to determine the impact of increased cystine-glutamate exchange on the development of plasticity-dependent cocaine seeking. Although N-acetylcysteine administered before cocaine did not alter the acute effects of cocaine on self-administration or locomotor activity, it prevented behaviors produced by repeated cocaine including escalation of drug intake, behavioral sensitization, and cocaine-primed reinstatement. Because sensitization or reinstatement was not evident even 2-3 weeks after the last injection of N-acetylcysteine, we examined whether N-acetylcysteine administered before daily cocaine also prevented the persistent reduction in system x(c)- activity produced by repeated cocaine. Interestingly, N-acetylcysteine pretreatment prevented cocaine-induced changes in [35S]cystine transport via system x(c)-, basal glutamate, and cocaine-evoked glutamate in the nucleus accumbens when assessed at least 3 weeks after the last N-acetylcysteine pretreatment. These findings indicate that N-acetylcysteine selectively alters plasticity-dependent behaviors and that normal system x(c)- activity prevents pathological changes in extracellular glutamate that may be necessary for compulsive drug seeking.
Muthmainah M, Sketriene D, Anversa R, Harris E, Griffiths S, Gogos A Pilot Feasibility Stud. 2025; 11(1):19.
PMID: 39972374 PMC: 11837714. DOI: 10.1186/s40814-025-01598-5.
Cuocina M, Aiello G, Cutrufelli P, Rampello M, Rapisarda L, Rodolico A Front Pharmacol. 2024; 15:1462612.
PMID: 39309000 PMC: 11412889. DOI: 10.3389/fphar.2024.1462612.
De Felice M, Szkudlarek H, Uzuneser T, Rodriguez-Ruiz M, Sarikahya M, Pusparajah M Biol Psychiatry Glob Open Sci. 2024; 4(6):100361.
PMID: 39257692 PMC: 11381987. DOI: 10.1016/j.bpsgos.2024.100361.
Astrocyte-Neuron Interactions in Substance Use Disorders.
Harder E, Franklin J, VanRyzin J, Reissner K Adv Neurobiol. 2024; 39():165-191.
PMID: 39190075 DOI: 10.1007/978-3-031-64839-7_7.
Fentanyl-induced reward seeking is sex and dose dependent and is prevented by D-cysteine ethylester.
Knauss Z, Hearn C, Hendryx N, Aboalrob F, Mueller-Figueroa Y, Damron D Front Pharmacol. 2023; 14:1241578.
PMID: 37795030 PMC: 10546209. DOI: 10.3389/fphar.2023.1241578.